Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: Direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin

Jacob Strahilevitz, David C. Hooper*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: Direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin'. Together they form a unique fingerprint.

Medicine & Life Sciences